Groups | Experimental procedures |
---|---|
(1) Control | 100 μL 0.9% saline injected intratumorally |
(2) FeN200@GOx@M | 100 μL FeN200@GOx@M (1 mg/mL) injected intratumorally |
(3) UTMD | 100 μL SonoVue solution injected intratumorally, followed by ultrasonic irradiation |
(4) FeN200@GOx@M + UTMD | 100 μL FeN200@GOx@M (1 mg/mL) and 100 μL SonoVue solution injected intratumorally, followed by ultrasonic irradiation |